PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.02%
Revenue growth 1.25-1.5x MRVL's 4.41%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
7.03%
Gross profit growth 1.25-1.5x MRVL's 4.75%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
10.15%
EBIT growth below 50% of MRVL's 25.76%. Michael Burry would suspect deeper competitive or cost structure issues.
10.59%
Operating income growth under 50% of MRVL's 25.76%. Michael Burry would be concerned about deeper cost or sales issues.
2.86%
Net income growth under 50% of MRVL's 55.00%. Michael Burry would suspect the firm is falling well behind a key competitor.
3.62%
EPS growth under 50% of MRVL's 57.14%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
3.70%
Diluted EPS growth under 50% of MRVL's 52.38%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.61%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.80%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.21%
Dividend reduction while MRVL stands at 0.94%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
64.21%
Positive OCF growth while MRVL is negative. John Neff would see this as a clear operational advantage vs. the competitor.
70.86%
Positive FCF growth while MRVL is negative. John Neff would see a strong competitive edge in net cash generation.
61.96%
10Y revenue/share CAGR above 1.5x MRVL's 8.03%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
48.84%
Positive 5Y CAGR while MRVL is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
31.55%
Positive 3Y CAGR while MRVL is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
375.35%
10Y OCF/share CAGR 1.25-1.5x MRVL's 282.86%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
205.86%
Positive OCF/share growth while MRVL is negative. John Neff might see a comparative advantage in operational cash viability.
135.70%
Positive 3Y OCF/share CAGR while MRVL is negative. John Neff might see a big short-term edge in operational efficiency.
222.83%
Net income/share CAGR at 50-75% of MRVL's 443.41%. Martin Whitman might question if the firm’s product or cost base lags behind.
140.33%
5Y net income/share CAGR 1.25-1.5x MRVL's 99.38%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
113.67%
3Y net income/share CAGR above 1.5x MRVL's 21.62%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
43.90%
10Y equity/share CAGR in line with MRVL's 44.45%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
8.47%
Positive 5Y equity/share CAGR while MRVL is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
10.29%
Positive short-term equity growth while MRVL is negative. John Neff sees a strong advantage in near-term net worth buildup.
520.27%
Dividend/share CAGR of 520.27% while MRVL is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
121.41%
5Y dividend/share CAGR above 1.5x MRVL's 0.76%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
81.19%
Our short-term dividend growth is positive while MRVL cut theirs. John Neff views it as a comparative advantage in shareholder returns.
6.67%
AR growth well above MRVL's 4.07%. Michael Burry fears inflated revenue or higher default risk in the near future.
2.85%
We show growth while MRVL is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
5.83%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
0.54%
50-75% of MRVL's 0.90%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
24.23%
Debt growth of 24.23% while MRVL is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
-0.26%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
1.85%
SG&A growth well above MRVL's 0.81%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.